Vogt-Koyanagi-Harada syndrome: what neurologists need to know

Pract Neurol. 2019 Aug;19(4):278-281. doi: 10.1136/practneurol-2018-002165. Epub 2019 Mar 19.

Author

Christian J Lueck^{1

2}

Affiliations

¹ Neurology, The Canberra Hospital, Canberra, Australian Capital Territory, Australia christian.lueck@act.gov.au.
² Australian National University Medical School, Canberra, Australian Capital Territory, Australia.

PMID: 30890585
DOI: 10.1136/practneurol-2018-002165

No abstract available

Keywords: meningitis; papilloedema; visual loss; vogt-koyanagi-harada.

Publication types

Editorial

MeSH terms

11-beta-Hydroxysteroid Dehydrogenases / therapeutic use
Humans
Immunosuppressive Agents / therapeutic use
Uveomeningoencephalitic Syndrome / diagnosis*
Uveomeningoencephalitic Syndrome / drug therapy
Uveomeningoencephalitic Syndrome / physiopathology

Substances

Immunosuppressive Agents
11-beta-Hydroxysteroid Dehydrogenases